K-Hole (Articles)
Clinical Fiction: How RUO Websites Quote Imaginary Research“Not for human consumption,” says the label. Here’s a human trial, says the sales page. And “fictional,” says the trial itself. Apparently, checking the reference wasn’t part of the research.Krysia
Clinical Fiction: How RUO Websites Quote Imaginary Research“Not for human consumption,” says the label. Here’s a human trial, says the sales page. And “fictional,” says the trial itself. Apparently, checking the reference wasn’t part of the research.Krysia
Reta’s Rivals Are Waiting in the WingsEli Lilly is fiercely protective of retatrutide. That has not stopped everyone else chasing the same prize.Krysia
The Battle Over America’s Peptide Market: PSM Challenges the Push for Expanded AccessAs a pharmaceutical-industry-linked coalition asks the FDA to block seven peptides, medical and commercial organisations are meeting White House officials over a proposed access policy.Krysia
Compounding vs the Grey Market: What Do Peptide Buyers Actually Want?Can US pharmacies win over grey-market peptide buyers on price, quality and trust?Krysia
Compounding Pharmacies in the Spotlight: Recalls, Contamination Concerns and HospitalisationsA tirzepatide recall, contaminated glutathione concerns and hospitalisations put US compounding pharmacies under scrutiny.Krysia
The Peptide Crackdown: £2 Million Seized in the UK as Australia Reports 1,180 Hospital VisitsTwo countries, two developments, and growing pressure on the grey-market peptide trade.Krysia
Jingmei Biotech / KimZe (JM Biotech, JINGem, Honesty, Kanazawa): When a Good Vendor Goes BadA vendor can deliver successfully ten times and disappear with your money on the eleventh.Krysia
Black Mould, Hidden Lab Records and Dirty Equipment: Inside the FDA's Chinese Peptide Factory InvestigationsFDA inspections reveal serious quality-control failures at two Chinese GLP-1 suppliers, with earlier records showing problems dating back years.Krysia
Big Pharma, Big Harm: Serious Adverse Effects From Branded PeptidesDeaths, permanent vision loss and hospitalisations linked to prescribed peptides, from Mounjaro and Ozempic to medicines beyond GLPs.Krysia
Before the Vial: Inside the Peptide API Supply ChainHow raw peptide is bought, purified and passed downstream, and why a “99% purity” result does not tell the whole storyKrysia
Eli Lilly vs LiveWell Peptides: When “Research Use Only” Meets “Getting Started with Peptides”Retatrutide, influencer codes and a peptide guide: Lilly challenges LiveWell’s “research only” claims.Krysia
The Living GLP-1 Factory: A New Patent for an Old Idea?FibroBiologics proposes turning engineered cells into living GLP-1 factories. But how new is the technology, and can it be safely controlled?Krysia
Vanguard vs the Chinese Manufacturer: The Eloralintide Mystery Gets BiggerConflicting eloralintide results, suspected retatrutide contamination and a cross-laboratory investigation underwayKrysia
Blue, Green or Genuine? Can EDTA Tell You If Your GHK-Cu Is Real?The next Brazilian home test, this time for copper peptidesKrysia
K-Hole's Fastest Vendor “Vetting” EverWelcome to K-Hole, where a $48 peptide bargain becomes a million-dollar shopping trip before anyone's placed an order. 😂Krysia
Chimera’s Extraordinary Statement: Orders Open, Questions ClosedFactory claims, unfulfilled orders and an announcement that offered customers accusations instead of answers.Krysia
Damian Krawczyk on Biowell and the Black Hawk RaidBiowell’s founder on building a peptide brand, the Black Hawk raid and the case against him.Krysia
Paying for Peptide Testing: Is a Yes or No Enough ?A debate over Janoshik’s reports raises questions about value for money, customer expectations and access to the evidence behind a resultKrysia
Inside SteriGenix: The Chromatograms That Didn’t Need a ChromatographA forensic look at 3,003 SteriGenix COAs and the evidence behind their resultsKrysia
When the Lab Gives the “Wrong” AnswerWhat happens behind the scenes when peptide testing produces a result the customer does not want?Krysia
Lilly Went After a Peptide Seller, and Sued a Transport CompanyLilly’s own dismissal notice explains why it dropped Astra LLC, while continuing its case against the unidentified operator of Astra Peptides.Krysia
Saudi Arabia Joins the War on Grey-Market PeptidesOnline sellers face potential penalties of up to five years in prison and SAR 5 million in fines, following an earlier investigation involving gym trainers and retatrutide.Krysia
When the Lab Asks You to Supply the Reference StandardCan a commercial peptide with a 99% purity certificate provide a reliable benchmark for identity, purity and milligrams per vial?Krysia
Why Your Peptide COA May Prove Less Than You ThinkInside Lab4Tox’s LC-MS/MS laboratory: weak identification methods, unreliable suppliers and the contamination risk hidden beyond purity and quantity.Krysia
Apex Peptides: The Dark Side of “Research Use Only”Federal agents appeared to be searching a waste-management business. The trail led back to Apex Peptides, and a much larger group of companiesKrysia
The Benzyl Alcohol Problem: Excipient, Contaminant or Impurity?Labs are finding it repeatedly in lyophilised peptide vials, but disagree over whether it should reduce the reported purityKrysia
Has the Grey Market Worked Out What UBT251 Is?It’s appearing on API supplier lists and the first public advertisements are already up. This could be the grey market’s next triple agonist.Krysia
Benzyl Alcohol in Lyophilised Peptides: What the Five-Lab Dispute Actually ShowsWhat happens when labs treat the same peak differentlyKrysia
A Freeze Dryer Is Not a Sterile Injectable FactoryWhy vials, filling lines and people in gowns don’t prove that a peptide was made as a sterile injectableKrysia
The ISO Logo Is Not Enough: Is Your Peptide Test Actually Accredited?A laboratory can hold genuine ISO/IEC 17025 accreditation while its peptide testing remains outside the accredited scope. The certificate is only the beginning of the investigation.Krysia
The 99.5% HGH QuestionWhen “purity” depends on the method behind the numberKrysia
Inside Finnrick: Peptide Testing, Paywalls, Privacy and the Problem With OverfillCEO Raphaël Mazoyer answers questions about disputed results, laboratory selection, vendor payments, data security and what Finnrick believes the grey market is getting wrongKrysia
Same Box, Four Labs; Why the Endotoxin Results Differed.What do four different endotoxin tests actually prove about the same product?Krysia
Fermentation Could Help Meet the Next Wave of GLP-1 DemandAs the market for GLP-1 medicines expands, Virtu Pharmako is scaling a bacterial fermentation process designed to produce semaglutide and other peptide ingredients more efficiently.Krysia
Inside a Chinese “GMP” FactoryA glimpse inside the ageing steroid operations that fed China’s early peptide boom, but not the industry as it looks today.Krysia
Is Your Reta Really Reta?An Aib-removal claim raised a bigger question: what does routine testing actually prove?Krysia
Should You Freeze Reconstituted Reta? The Tests Don’t AgreeThe warning has been pretty emphatic: don’t freeze reconstituted Reta. Not once. Not ever. But does the testing actually support that?Krysia
Pharma Grade or Pharma Theatre? The Machine Isn’t the MethodDoes using the same HPLC brands as Big Pharma make a laboratory “pharma grade”? Not quite.Krysia
The Lobster Trap: Same HGH Kit, Different Result. So What Actually Changed?Lobster has managed to turn what looked like a fairly simple complaint about HGH testing into a much more interesting question.Krysia
UPDATE: THE SELANK BIURET STORY JUST GOT MORE INTERESTINGTwo Uther batches stayed blue. Another vendor’s Selank turned positive.Krysia
Fake Hospira Follow-Up: RH7241 Is a Real Pfizer Lot and the “Fake” Water Tested GoodPfizer has now confirmed the lot exists, PeptideTest says the suspect water passed his own testing, and the original counterfeit scare increasingly looks like a packaging change.Krysia
Those White Rings in 5-Amino; Bubbles, Crystals or Something Else?The same strange pattern has been appearing for months. The strongest explanation points to a freeze-drying defect, but nobody has yet analysed the rings themselves.Krysia
ASK ANELA: 25 Protocols, GHK-Cu and the Questions K-Hole Wanted AnsweredThe creator of the Anela Protocols answers K-Hole members directly on GHK-Cu, Epitalon, dosing, filtration, testing and moreKrysia
Samsung’s Latest Upgrade: $1.8 Billion of PeptidesInside the billion-dollar race to build the factories behind the GLP-1 boomKrysia
Fake Hospira? The Closer We Looked, the Less Certain It BecameA suspect March 2028 lot, missing crimp markings, matching Reddit photographs and a purported Pfizer certificate, but still no definitive answer from PfizerKrysia
When BAC Water Starts Blowing BubblesFrom “bubbles are friends” to “you got the worm”Krysia
Eloralintide;The First Post Is Not the ExperienceI tracked 66 people reporting Elora use. Some felt nothing, some could barely eat, and quite a few were telling a very different story several weeks later.Krysia
ERP (Again), the Failed Elora and the Admin Who Could “Make It All Go Away”A failed Elora test exposed more than the wrong peptide. It opened a window into how ERP handles bad results, refunds and criticism.Krysia
Purple, Blue Or Bunk?The Poor Man’s Peptide Test: What Can Biuret Actually Tell You?Krysia
Is This the End of the Chinese Vendor Middleman?When a Mandarin-speaking buyer went looking locally in China, she found peptide prices so low they made the vendors we call “direct” look rather less direct.Krysia
Can a Laboratory Report Purity for a Peptide Blend?Janoshik Says No. Other Labs Say Yes, but Only as a Qualified Relative ResultKrysia
How to Operate an RUO Website: All-in-One for Dummies, FDA EditionA step-by-step guide to keeping your website clean and giving the FDA a well-deserved break (FOR FREE)!Krysia
Five Warning Letters and a Problem for the RUO Peptide MarketFive US peptide vendors were hit on the same day, and FDA looked straight past the “Research Use Only” disclaimers to the claims, studies, calculators, guides and BAC water surrounding them.Krysia
The €25 HGH Test: Can a Stick Tell You If Your HGH Is BunkA Cheap First-Line Check for Whether There’s Actually HGH in the VialKrysia
My Third-Degree Interview With Uther; a blast from the pastA factory, a crypto payment, the “vail” police and 35.37mg of TirzKrysia
Before the Vial: The API Question Nobody AsksYour Vial May Test Perfectly, But Nobody Has Told You What Happened Before It Got ThereKrysia
Excerpts from K-Hole Lab ChatHGH Filtration, Dimers, Freeze-Thaw Cycles & Reference StandardsKrysia
Bioglutide; What Happens When a Fake Drug Reaches the Supply Chain?And what responsibility does a vendor have when the factory says it’s real?Krysia
Jike Biotech: 195 Kits, Six Products and No PeptideWendy blames a rogue raw-material supplier, but even the replacement products returned no analyte detected.Krysia
The Man Who Didn’t Want Credit, Until He Was Called “a Customer”An urgent correction for Moggerzilla, founder of endotoxin journalism, reluctant public figure and claimant to a free article he calls “my work”Krysia
Endotoxin Pass, But Against What?How testing labs can perform an endotoxin test, issue a result and still leave the customer unable to tell what has actually been ruled outKrysia
The COA Shell Game: What Happens When a Vendor With Fake COAs Is Already Listed on Peptide Critic?Simms Research says every batch is independently tested. Kovera says it never issued the COAs carrying its name, while Peptide Critic’s promised warning is nowhere to be seen.Krysia
From Bella’s T30 Vial to the ChromatogramIn the final part of my Analiza Białek tour, Max prepares and runs my Nanjing Peptide sample through HPLC, and explains why “tadalafil” appearing on the software does not mean tadalafil was found.Krysia
First the Vendors. Now the Influencers: The Peptide Crackdown Moves Onto Social MediaTwo major peptide channels disappear from YouTube as Australia seizes more than $120,000 in peptides and steroids, and warns that influencers and affiliates may be held accountable.Krysia
Thanks for the Credit, But You Forgot the Part Where the Fentanyl Tests Were False PositivesMarek Health used my fentanyl reporting to promote its services. The screening reactions have since proved to be false positives, yet its subscribers have never been given the outcome.Krysia
Same Vial. Three Labels. Three COAs.The Freedom example that started a wider debate about rebranded laboratory reports.Krysia
Eli Lilly Says It's Coming for the Retatrutide Black Market. Bella on WhatsApp Doesn't Seem Worried.The first targets are six American businesses. Driving them out may send buyers straight to China; only pressure on payments, warehousing and delivery threatens the trade itselfKrysia
Inside The Bioglutide Support GroupA Peek Inside a Support Group for a Non Existent Drug Nobody Can Actually IdentifyKrysia
Part 2/3. Inside Analiza Bialek LabInside Max’s Lab: New HPLC Machines, 98% Epitalon, Endotoxin Testing and the Search for Heavy MetalsKrysia
The Legend Pharma Rabbit Hole: Zero-IU HGH, Bosa and the Panda RebrandsTwo HGH group buys arranged through the same Legend rep tested at 0 IU. What began as two failed batches opened a much murkier trail involving Amy, Aimi, Cynthia, Bosa, Well Wise and Legendary PandaKrysia
The Freedom Special: When the Chromatogram Does Not Match the 99% PurityTesamorelin, IGF-LR3 and Epitalon reports raise questions about Freedom’s peak integration, chromatographic separation and whether its purity figures can be independently checked.Krysia
Another One Bites the Dust: Hoss and the COA That Belonged to Somebody Else“I test my own shit. I don’t use other people’s.” Seven minutes later, a receipt showed Hoss sending a COA that verified to another supplier.Krysia
The Peptide Is 99% Pure, but does it actually work in the body?A clean chromatogram can identify the key, but does it prove the key can turn the biological lock?Krysia
ILS Reports 0%. Freedom Finds 99%: Four Results That Demand An ExplanationFour products failed identity testing at ILS Laboratories. Samples from the same batches were then sent to Freedom Diagnostics, where all four were identified using LC-MS.Krysia
The Rick Method of Customer RetentionFlattery, tough love and photographic evidence nobody asked for.Krysia
First SS-31, Now Epitalon: The Lab Wars Return And It Gets PersonalThe laboratories largely agree that Epitalon purity is lower than advertised, but are now fighting over which testing methods are needed to prove itKrysia
The Great Epitalon Purity DebateThe laboratory debate challenging how Epitalon purity is measured.Krysia
Same Batch T60, Three Labs, and One Result Doesn’t Add UpTwo labs found over 70 mg, a third found 62.3mg. The discussion that followed exposed much larger questions about how testing labs calculate quantity.Krysia
Beebo off the Hook ? Multiple 5-Amino-1MQ Samples Test Negative for FentanylTen samples, including one believed to be from the affected vendor tested negative when the strips were used as instructed, while LC-MS/MS found none of 60 fentanyl related compoundsKrysia
Same Kit. Two Vials. Two Extreme Endotoxin Failures.Both results were extremely high, but the fivefold difference exposes the limits of testing a single vialKrysia
XTP R30: The Story Behind the StoryCustomer-funded testing, disputed independence and a fight over who controlled the results, before XTP blamed “malicious competitionKrysia
The Most Tested Batch That Never PassedXTP’s R30 changed in strength, purity and even identity, but never delivered the consistent 30 mg batch customers were sold.Krysia
Inside Vanguard’s Failed Samples Log2,106 failures, a recurring contaminant called “faketide” and a vendor blaming shipping heat for zero-peptide vials.Krysia
Nico, XBT and Pepe: The Spanish Group-Buy Organiser Behind BothA supposed Chinese representative, a concealed Spanish organiser, an undisclosed behind-the-scenes operator and a failed logistics partnership that ended in allegations and an admitted threatKrysia
The other side of the Mia Changsha Australian GB927 Kits Ordered, One Stock Shortage and an Australian Group Buy That SpiralledKrysia
BriStaxx; When Group Buys Go BadBriStaxx built her reputation through successful group buys. Then the updates slowed, the testing disappeared and customers began comparing what they were still owed.Krysia
Changsha MIA: She Vanished, Then Returned for the RetractionRestricted groups, forgotten orders, disputed products, and one final request to make the story disappear too.Krysia
Axiom Analytics: A Real Company, but Is There a Real Laboratory?A recently registered website, a Prague address shared with a massage business, catalogue photographs presented as “our equipment” and a purification system described as high-resolution LC-MS.Krysia
When Lab Chat Became an Equipment ShowroomTwelve HPLCs, an Orbitrap Exploris, three Bruker systems and enough laboratory dinosaurs to open a museum.Krysia
The Curious Case of the Colour-Changing HCG CapsA US reseller ordered 15 kits of HCG from Homopeptide. The product was underfilled, failed sterility, and came with a COA showing entirely different caps.Krysia
Hui Hai’s Factory Tour Comes With a Familiar ViewA "borrowed" failed customer test, a production video made for another vendor and several questions about what Hui Hai actually owns.Krysia
The Clock Is Ticking for the FDA’s Peptide DecisionWith the July 23 to 24 PCAC meeting just days away, the battle over seven peptides is reaching its climaxKrysia
Fentanyl in a 5-Amino-1MQ liquid, or a Precursor Setting Off the Strips?Three positive screening results, two laboratories and one unanswered question: what is actually inside the vial?Krysia
One Question About UZORAK and Suddenly Janoshik Was Running Customer Support in the K-HoleJanoshik Proves to Be Quite the Sport as One Laboratory Complaint Turns Into a K-Hole Q&A, Technical Review and Supercar ConsultationKrysia
APM Peptides: From Apology to AccusationAPM admitted raw-material failures, failed metals testing and inadequate quality control, then accused the customer of faking the reports and extorting the company.Krysia
The 0.5 mg Elora Nobody Wants to ClaimQH says it only promoted it, APKX says its version passed “internal testing,” and the supplier behind the 0.5 mg result remains a mystery.Krysia
Can a Narcissist Biohack Their Way to Being a Nicer Person?Oxytocin, neuroplasticity and the uncomfortable truth; there is no simple shortcut to kindnessKrysia
No Peptides, No Platform: Fresh Wind’s Bunk Products and the Forum That Banned the CustomerTestides lab found missing and mismatched peptides. Fresh Wind blamed customs, while its sponsored forum, GLP-1 Forum, banned the customer trying to report it.Krysia
The Day XYZ Jack's Channel Brought In JanoshikOne underfilled HGH vial turned Jack’s channel into a scientific showdown, a supercar display and a debate over duplicate COAs.Krysia
Jack of All CompaniesFrom XYX and Nanjing Biotech to HRT, XYZ and Sulan; the company behind this supplier remains surprisingly difficult to identify.Krysia
Attack of the Janoshik ClonesAnother counterfeit verification website has appeared, this time linked to COAs supplied by the company, Gab Peptides.Krysia
Biopeptide Sciences; Seven Tests. Seven FailuresFailed testing, disputed COAs and customers left battling for their money while BioPeptide Sciences denied the claims.Krysia
Aotai Biotech Warning: 22 Tests. 22 Failures.Freedom Diagnostics found repeated identity failures, unknown non-peptide substances and major underfilling across multiple products.Krysia
The Barn ChroniclesFrom trusted vendor to testing controversy: the complete story behind RT10, KLOW and KPV.Krysia
The Peptide Rabbit Hole Gets DeeperFrom Shanghai trade shows to private factories: one distributor’s account of how the Chinese peptide market really works.Krysia
The 30-Day Silence: What Happened to LN Peptides?Exit scam, raid, or internal collapse, customers are still waiting for proof.Krysia
The Next Chapter for PeptidesIn this final part of my exclusive in-person interview, Jeff Cohen discusses future enforcement, pharmaceutical competition and the evolution of the peptide market.Krysia
RUO vs PUO: What’s the Difference?In this exclusive in-person interview, Jeff Cohen explains clinician responsibilities, peptide sourcing and why PUO is growing.Krysia
RUO, Retatrutide and Regulatory RiskPart of my exclusive in-person interview with Jeff Cohen exploring the future of the peptide industryKrysia
The Tenth VialNine are legitimate. One is not. Somewhere between the laboratory and the customer, the truth disappears.Krysia
A New Addition to the Mysterious Brown Biology NetworkFrom Peptide Mom to Light Peptide, Brown Biology continues to surface across the peptide market.Krysia
Vendor Beef: The Case of the Vanishing WatermarkSQ Peptide, Tanran receipts, missing watermarks, and an alleged AI cleanup job that left the group chat reaching for popcorn.Krysia
When a Vendor Launch Goes Wrong: The Story Behind the ROP Price List ControversyFrom premium pricing to undisclosed mark-ups: how a vendor launch became a case study in transparency, trust and conflicts of interest.Krysia
The Real Dogs Behind Nova Vita RX’s Wildest AdsA rescue Frenchie with max side-eye, a dog named Gru turned “Tank,” and the weirdly brilliant backstory behind a telehealth campaign nobody can ignore.Krysia
What Is the APA (American Peptide Association) and What Does It Actually Do?In this exclusive in-person interview, Jeff Cohen explains why the American Peptide Association was formed, who it’s for, and what it hopes to achieve.Krysia
The Mistakes That Sank the TB-500 NominationAn analysis of the FDA’s concerns and the weaknesses that undermined the TB-500 submission.Krysia
Lyobeads: Old Technology, New MarketingHow pharmaceutical freeze-drying technology found its way into the peptide world.Krysia
Smoke, Mirrors and Reta30Failed testing, black-bag shipments, supplier disputes and a manufacturer that said: “These aren’t our products.”Krysia
The Warehouse SwitchA failed Janoshik test showing zero peptide, a logistics mix-up, and the mystery of the missing R20.Krysia
Breaking Trust; The Lab That Claude BuiltA backyard peptide start up, a community-funded vision, and the growing list of questions nobody could get answered.Krysia
Will The Real LKZ Please Stand UpOne failed Retatrutide test exposed competing claims, coded manufacturer names, rival communities and a vendor nobody could clearly define.Krysia
The Peptide Mom ParadoxFake-looking COAs from a fake lab, real customer deliveries, and the unanswered question at the centre of it all.Krysia
Trusted Until it isn'tHow a long-established vendor, a repeat customer and an alleged $50,000 loss challenge assumptions about what “trusted” really means.Krysia
Spam or Relationship Building?The concept of “guanxi” may explain why Chinese peptide reps approach customers very differently from their Western counterpartsKrysia
Verified by Whom?Inside the BlankChem Quality Control Division and the Questions It Leaves UnansweredKrysia
The €250 Raid: Seven Months LaterA small peptide order became a dawn raid. Seven months on, the buyer is still waiting, paying lawyers, and facing possible charges.Krysia
Do Drexa’s COAs Pass Drexa’s Test?The company published a guide on spotting suspicious Certificates of Analysis. So I applied the same checklist to its own paperwork.Krysia
Following the TM BioWater TrailFDA registrations, NASA connections, GMP claims and a fake COA: what the records actually show. and what remains unanswered.Krysia
Customer Support: TranslatedAfter thousands of orders, one US vendor reveals what common customer questions sound like from the other side of the screen.Krysia
Only 28 Days?A 120-Day Stability Assessment of Hospira Bacteriostatic Water Under Three Storage ConditionsKrysia
Bac Water WarsWhat PTDS Found When Commercial BAC Waters Were Actually TestedKrysia
The Price Per Kit or Per Vial Controversy ContinuesFive industry voices. One disputed price list. And a growing consensus that the figures are per vial, not per kit.Krysia
Inside the cost of a peptide kitAn experienced buyer/ fill-finisher explains raw pricing, manufacturing costs, freight forwarding and why some surprisingly low quotes may not be impossibleKrysia
The Controversial Saga of the origins of Baba CainAliases, factory raids, rivalries, forum investigations and the story behind one of the peptide community’s most debated figuresKrysia
The Bathtub Boys Go Down the DrainFrom Reddit warnings and crystallized vials to federal agents, seized property and allegations of a $15 million weight-loss drug operation.Krysia
Direct Peptides and Horizon Analytical (Part 2)Inside the relationship behind the COAsKrysia
The Déjà Vu VendorTwo vendors, three matching COAs, one very familiar interviewKrysia
The Peptide Mom ExperienceTracking glitches, celebrity endorsements, phantom labs and a package that actually arrived.Krysia
The Interview That Broke the LabHow a routine vendor interview exposed a fake peptide testing ecosystem, and how the community crowdsourced the intelligence that unravelled itKrysia
Janoshik Weighs In On Elora TestingWhen The Car Runs Perfectly ; Why Janoshik thinks deeper Elora testing may not be necessaryKrysia
The End of Grey-Market HGH?How FDA enforcement, biologics regulation and collapsing shipping routes may be pushing HGH into a new eraKrysia
Jano King?How one peptide testing lab became the grey market’s default referee, and why the community is starting to question what happens when trust centralises too far.Krysia
So You Want to Buy an RUO Peptide Company?Inside the Direct Peptides MachineKrysia
The Elora Testing Debate ContinuesWhy the Structural Verification argument is becoming more complicatedKrysia
The Return of AmylinWhy The Amylin Field Suddenly Became Hot AgainKrysia
The Trouble With EloraWhy this engineered amylin agonist may become the grey market’s biggest analytical challenge yetKrysia
China’s 2026 Pharma Crackdown and the End of “Easy Shipping”Why more grey-market vendors are suddenly sounding like exhausted freight coordinators instead of sales repsKrysia
Inside the "zero peps" supply chainHow bunk raws and missing QC may be fuelling the latest peptide failuresKrysia
Sold as Bioglutide, Tested as NA-831Inside the growing mismatch between NA-931 marketing and what the analytical data actually showedKrysia
The GYC Impersonation ProblemReal Janoshik links, broken trust badges, confused customers, and a storefront accused of operating under another vendor’s name.Krysia
Battle of the labs; The AftermathHow the “mannitol vs PVDF” fight turned the SS-31 lab war into a battle over raw data, workflow setup and scientific interpretationKrysia
Battle of the Labs: The Dirty EditionHow the FSD SS31 dispute turned into a public war between two EU labs, over raw data, mannitol vs PVDF, AI interpretation, and whether it is actually safe to use or not.Krysia
Battle of the Labs: The Equipment EditionWhen identical-looking peptides produce completely different results depending on the machine, method, and interpretation behind the report.Krysia
Not Hospira. Just Styled Like It.The grey market's own version of pharma cosplay.Krysia
99% Pure. 100% Not Retatrutide.How Testides Lab Canada uncovered multiple “Retatrutide” samples that tested as Tirzepatide instead.Krysia
Bad Romance: The Rise and Fall of Lady KaKaHow refunds, operational chaos, the Olympus fallout and collapsing trust turned a rising grey-market vendor into a cautionary taleKrysia
The Ranhang Rabbit HoleFrom “professional peptide manufacturer” to pig farming equipment, following the trail behind the WhatsApp vendorKrysia
The 20-Year-Old Who Tried to Start a Peptide CompanyHow a 20-year-old e-commerce founder went from seeing opportunity to questioning everything behind the vialKrysia
The Cold Outreach ExperimentFrom “Dear Friend” to Delivered Order, what actually happens when you replyKrysia
So You Want to Sell Peptides Without Ever Touching Them?Inside the platforms turning supply chains into storefrontsKrysia
From Copyright Claims to Trademark ThreatsJust normal life in this crazy grey market communityKrysia
Krysia's FREE Guide to "Going Grey"A practical guide to navigating vendors, risk, and uncertainty for those new to this worldKrysia
BlankPeptides: Gated for Compliance. Built for Conversion.Inside the pressure funnel behind a “research peptide” brandKrysia
CGMP Claims in the RUO Peptide Research SpaceWhat cGMP actually means and why RUO Claims don't line upKrysia
The Made in USA RUO cGMP ContradictionWhen US manufacturing claims and cGMP language don’t match RUO realityKrysia
Created yesterday. Selling historyHow a brand new peptide site is claiming years of experience and thousands of orders.Krysia
NitroX Peptides: When a COA Looks Legit but Proves NothingHow vendor branded certificates, wrong CAS numbers, and missing data turn “lab verified” into marketingKrysia
Why “Vetted” Simply Doesn’t Exist in the Grey MarketThe word everyone uses, but no one can proveKrysia
Direct From China: The Risks They Don’t Tell YouThe €250 Order That Triggered a Dawn Raid in the EUKrysia
The Brazil Orders; From “We’ll Ship DHL” to 30%When agreed shipping terms were ignored and losses followedKrysia
Hidden Hazards in the Grey Market: Uncovering Cresol Contamination in PeptidesWhen “High Purity” Isn’t Pure Enough: The Risks Lurking in Your Lyophilised VialsKrysia
The Reseller Problem: When a Bad Batch Keeps MovingWhat happened once the results were already inKrysia
Counterfeit TrustHow a lab identity was repackaged into a closed-loop verification systemKrysia
Same peptide; Different stabilityWhy liquid pharma and lyophilised products behave very differently over time.Krysia
High Purity, Hidden DegradationHow advanced analysis reveals degradation hidden behind high purity resultsKrysia
When Shipping Delays Become a StoryHow fragmented reports across vendors and platforms turn disruption into a “crackdown” narrativeKrysia
The Trouble with ERPHow one underdosed SS31 uncovered a broader pattern of product, policy, and support failuresKrysia
The Adamax Problem; Part 2Backbones, missing modifications and how labs test compounds with no clear standardKrysia
The problem with AdamaxWhy cheap “designer peptides” are rarely what they claim to be.Krysia
Shipping Paused, Payments Flagged, What’s Actually Happening Behind the ScenesInspections are up. Vendors are pulling back. Now even crypto payments are starting to get flagged.Krysia
The "Same Batch" ProblemWhy traceability breaks down when “batch” no longer means what buyers think it doesKrysia
BiochemAPI Peptides Tests Which Fill Volume Works Best For the New 140mg TirzepatideHow 1ml, 1.5 ml and 2 ml fills were compared to see which cake holds up best in transitKrysia
Three Statements. Mixed Reactions.How the narrative changed and how it was received.Krysia
The GLP-1 Loophole That Was Never a LoopholeHow a narrow FDA exception is being stretched into a system, and why it collapses under its own logicKrysia
Jeep; We Recommend Buying Genuine Products.Inside JEEP’s endotoxin response, and the limits of what they actually stand behindKrysia
The Orange Cap ProblemA record endotoxin result, repeated failures, and a batch label mess that turned JEEP T30 into a market-wide warningKrysia
The Phoenix GB ScamPart 3; The Pivot & Re-OnboardingKrysia
The Cyco Story: Reship Promises, Missing MoneyInside the breakdown of a "trusted" vendor, and the orders that were never fulfilledKrysia
The Collapse of the RUO IllusionThey know the rules so why aren't they following them?Krysia
The Phoenix Group Buy ScamPart 2; The March 21 AnnouncementKrysia
Battle of the labs; The SS31 caseHow one sample created a divide among the Labs.Krysia
The Phoenix Group Buy ScamHow “seized shipments” turn into second profits and why the same buyers may pay twiceKrysia
The Phoenix Group Buy ScamHow “seized shipments” turn into second profits and why the same buyers may pay twiceKrysia
What GMP Means And Why It Doesn't Exist in the Grey MarketGMP is a system built on traceability, documentation and control, and without that system, the claim can't exist.Krysia
Peptide Sciences; What Happens When a Big Vendor DisappearsThe rise of clone domains, fake stores, and how SEO fills the gap before you noticeKrysia
Olympus Falls: Part 2- The FalloutThe KaKa call, blurred money trails, and a story that fractured in real timeKrysia
Shipping Delays, Seizures, and FedEx RumoursSeparating fact from rumour in a system under increasing scrutinyKrysia
SLU-PP-332 and the Problem With Pan-ERR AgonismWhat social media doesn’t tell youKrysia
Olympus falls; Part one- How it all blew upA vendor exit scam, a collapsed $60,000 GB and the decision that set everything in motionKrysia
Understanding the testing termsA simple guide to what HPLC-UV and LC-MS actually show, and what they don’tKrysia
Hidden in the Peak: How Testing Methods Change the ResultWhat the SS-31 case reveals about how different testing methods shape what we see, and what we missKrysia
Friendship in the Grey ZoneUseful, Until You’re Not ( updated )Krysia
The Ultra Modern ScamA fully constructed environment designed to feel legitimate at every stepKrysia
Behind the vial seriesVial Sterilisation and DepyrogenationKrysia
The Disappearance of SSA ( parts 5 &6)The Timeline to Impersonation, The Return of "SSA"and a "theory"Krysia
Behind the vial seriesHow vials are prepared before lyophilisationKrysia
Just another day in the Grey ZoneOne day of scams, impersonation and chaos and a very unexpected collaboration - told exactly how it happenedKrysia
Endotoxins in Grey Market Peptides: The Numbers You’re Reading Aren’t What You ThinkWhy <10, >100, and “estimates” often aren’t real measurements, and what endotoxin levels actually tell you about dose and manufacturing qualityKrysia
The Disappearance of SSA ( parts 3 & 4);The Replacement Vendor Scramble and Source BazaarKrysia
Vial vs Body; Tirzepatide and vitamin B12Understanding where interactions occur and what that distinction actually meansKrysia
The Disappearance of SSA (Part 2 of 6): The First Response Was Not Recovery It Was RegroupingThe first days after SSA vanished were defined not by recovery, but by improvised regrouping and information collapseKrysia
The Disappearance of SSA (Part 1 of 6): When Things Stopped WorkingA real-time breakdown of the SSA collapse separating fact from fiction and documenting what actually happens when a major grey market vendor goes dark.Krysia
Price Drift: When a “Discount” Isn’t a DiscountAdvertised low. Quoted high. Discounted… but not really.Krysia
Vial vs body; Tirzepatide + vitamin B12Understanding where interactions occur and what that distinction actually meansKrysia
Eli Lilly’s Tirzepatide + B12 WarningWhat Their Data Shows, and What It Still Doesn’t ExplainKrysia
The Cloudy Reta Problem:Why “99% Pure” Peptides Can Still Fail the Moment You Use ThemKrysia
Eli Lilly’s Tirzepatide + B12 WarningWhat Their Data Shows, and What It Still Doesn’t ExplainKrysia
Paid, Questioned, Abused, Banned; The Peptide Hub PatternHow multiple buyers followed the same path from payment to silence, abuse, and removalKrysia
The NAD Testing ParadoxWhy some labs report 99%+ purity, others refuse to give a number at all, and what NAD COAs are really measuringKrysia
GLP-1 Scrutiny Is Hitting Both Sides of the MarketRecent FDA warning letters to Novo Nordisk and Eli Lilly show that scrutiny in the GLP-1 market now extends to both manufacturers and compounders.Krysia
Beyond RUO: The Telehealth Compounding Pipeline Reshaping the Peptide IndustryHow underground factories, physician networks, and future 503A licensing may be rebuilding the supply chain.Krysia
The NAD Testing ParadoxWhy some labs report 99%+ purity, others refuse to give a number at all, and what NAD COAs are really measuringKrysia
The DDC List: The Regulatory Tool That Could Kill GLP-1 CompoundingHow nominations for semaglutide and tirzepatide reveal another front in the fight over GLP-1 compoundingKrysia
The Real Pressure Behind the end of RUOWhy Payment Processors May Be Reshaping The Peptide MarketKrysia
From RUO to PUO;How the peptide industry is relabelling the same supply modelKrysia
K-Hole Origins; My Road to GreyDear Friend, where's my refund (Audio Version)Krysia
When Screenshots Become EvidenceHow rumours spread before verification in grey market communitiesKrysia
Eli Lilly’s Tirzepatide + B12 Warning…and the Questions Still UnansweredKrysia
Delivered to Nobody; Part II: The Commission TrapWhen reship turns conditional and the blame gets pushed onto the organiserKrysia
Beyond RUO: The Telehealth Compounding Pipeline Reshaping the Peptide IndustryHow underground factories, physician networks, and future 503A licensing may be rebuilding the supply chain.Krysia
The Real Pressure Behind the End of RUOWhy Payment Processors May Be Reshaping the Peptide MarketKrysia
From RUO to PUO: The New Label Replacing RUOClarifying What “PUO” Actually MeansKrysia
Is RUO Ending? Inside the Infrastructure That Could Replace Peptide WebsitesAfter the shutdown of Peptide Sciences, a new distribution model; Telehealth, prescriptions, and compounding pharmacies, may already be taking shape.Krysia
Behind the vialFrom Solution to Vial: Manual Filling Under Laminar FlowKrysia
Behind the vial seriesUnderstanding manual peptide vial fillingKrysia
How Grey-Market Communities Engineer ReputationsManipulated Labels, Word Filters & BansKrysia
Who actually ships your peptides? Drop shipping explainedDrop-shipping, middlemen, and why batch/COA matching gets messy.Krysia
Why "Buying Direct from the Factory" isn't Always CheaperThe hidden economics of fill/ finish manufacturing, resellers, and the fragmented peptide supply chainKrysia
Behind the vial seriesReal Footage of the Lyophilisation ProcessKrysia
Behind the vial seriesInside the lyophilisation processKrysia
AI Just Designed an Obesity Drug. Now What?The real story behind AI drug discoveryKrysia
Alt accounts & the Art of DisguiseWhy changing the IP doesn't change the patternKrysia
From Cleaning to Crimping: A Vial Fill-Finish WalkthroughCourtesy of Aaron Biochemapi PeptidesKrysia
The "TinkyWinky Quadrilogy"Part 3; Wellnessnerd & The Midnight OrderKrysia
The TinkyWinky Quadrilogy; Evolution of a scammerPart 2; Battle of the WarehousesKrysia
The Newbie TaxHow an online “Grey Guide” funnels newbies straight into a vendor’s TelegramKrysia
Inside Uzorak, the new testing lab ( Part 2)Origins, Offer Design, Pricing Claims, and the Technical Clarifications People Keep MissingKrysia
Raising the Bar or Raising Expectations? Inside UZORAK testing lab (Part 1)A new lab, a bold pitch, and a closer look at what's data vs frameworkKrysia
Who Actually Ships Your Peptides?Drop-shipping, middlemen, and why batch/COA matching gets messy.Krysia
K- Hole Origins: My Road to GreyDear Friend, where's my refund? How a routine order turned into a months long refund negotiationKrysia
THE BIOGLUTIDE SCAMThe Miracle Drug That Never ExistedKrysia
The “TinkyWinky Quadrilogy”Part 1; the evolution of a scammer (and everyone else’s patience)Krysia
Shattered Dreams, Broken PromisesThe grey zone is full of big plans, and tiny follow through.Krysia
The 99% Purity TrapWhat HPLC-UV actually measures, what it can miss, and why “99%” doesn’t mean “safe.Krysia
PAE: The GB Organiser’s Guide to Not Being Asked AnythingHow one announcement accidentally reveals the entire risk model of a group buy.Krysia
Behind the Actress ( The Tracy QSC Interview revisited)Tracy Talks QSC, Busts, Dumpster meal, and the FutureKrysia
The Manufacturer MythWhy most grey market “factories” aren’t factories at allKrysia
PeptideScore: Trust Badges, Broken Links, Missing ProofWhat’s public, what’s locked, what doesn’t match, and why the only “A” rating mattersKrysia
The Refund That Requires Another Payment; The MIA Peptide ScamAnatomy of a Telegram Fee Ladder ScamKrysia
Ghost Mode EconomyThe accountability vacuum of the grey zoneKrysia
Delivered to Nobody: The Jacksonville Hub Seizure, the “Call the Police” Ultimatum, and the Community Split That FollowedThe Fallout: Factions, Fear, and the "call the police" loopKrysia
K-Hole Origins: My Road to GreyHow XCE went dark, and the post-XCE vendor scramble began.Krysia
Fight Club Rules vs Modern Reality: The Grey Market DivideEgos, Gatekeeping, and the Loud Minority ProblemKrysia
Delivered to Nobody: The Jacksonville Hub Seizure, the “Call the Police” Ultimatum, and the Community SplitWhen “reship guarantee” meets reality.Krysia
The Finnrick Job Post That Explains the Whole ThingFree testing is the headline. This is what’s underneathKrysia
How Credibility Gets Faked in the Grey MarketThe only real vetting is timeKrysia
TYPOS DON’T LIE The Price List + COA Trail That Exposed a Scam RingEPISODE 4
UNDERCOVER AS A CUSTOMER, BELLA AT CHECKOUTKrysia
Typos don't lie; The Price List + COA Trail That Exposed a Scam RingContact #4: Same Script, New Name (Luna)Krysia
Typos don't lie; The Price List + COA Trail That Exposed a Scam RingEpisode 2; Where the threads began to convergeKrysia
Herd Mentality in the Grey ZoneThe Uther Effect: How a Rumour Becomes RealityKrysia
Friendship is Conditional in the Grey ZoneUseful until you're notKrysia
Typos Don’t Lie: The Price List + COA Trail That Exposed a Scam RingPart 1, The Interview That Looked Fine (At First)Krysia
Life in the Grey Zone: When Servers Get NukedWhat happens when platforms pull the plug, when resilience becomes routineKrysia
Forever Young Pharmacy: Inside the Lab That Lost Its LicenceAn investigative exposeKrysia
From my TALES FROM K-HOLE SCAMIVERSE channelScam #2: Delivered Before It’s Picked UpKrysia
The Group Buy Field Guide: How Not to Get “Group Bye’d” 💀🛒How “group buy” became “group risk”Krysia
K-Hole Origins: My Road to GreyEpisode 2: “Transparent Green”Krysia
From my TALES FROM K -HOLE SCAMIVERSE channelEpisode 1 (Scam #1): Tracking SoonKrysia
K hole origins; My road to GreyEpisode one; Ozempic to China direct ( 22 Jan 2024)Krysia
The Refund That Never ComesAn episode from the China Peps Exposed Channel in K holeKrysia
The "Research Use Only" Peptide Conundrum: Myth vs. RealityWhat RUO actually means and what it doesn'tKrysia
Inside the Peptide Underground: A Month-By-Month Saga (PAE)Inside the Peptide Underground: A Month-By-Month Saga (PAE) is a narrative documentary series set inside PAE, a group buy Discord server where members pool money for bulk orders of research peptides, track testing results, and navigate constant platform risk.Krysia
No article in this category yet.